A型血-话题@MedSci

#A型血#

48篇内容 | 2401人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1678143, encodeId=995616e81430b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Lancet haemat：A型血友病患者采用emicizumab预防出血的效果和安全性, objectType=article, longId=165179, objectId=f5ca1651e910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5ca1651e910, replyNumber=0, likeNumber=86, createdTime=2020-02-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5ca1651e910, moduleTitle=Lancet haemat：A型血友病患者采用emicizumab预防出血的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5ca1651e910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678140, encodeId=44bf16e8140d0, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=诺和诺德的长效化凝血因子VIII（ESPEROCT）获FDA批准治疗A型血友病, objectType=article, longId=160654, objectId=f5c7160654df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5c7160654df, replyNumber=0, likeNumber=78, createdTime=2019-05-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5c7160654df, moduleTitle=诺和诺德的长效化凝血因子VIII（ESPEROCT）获FDA批准治疗A型血友病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5c7160654df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678145, encodeId=b56816e814521, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Nat Micro：肠道细菌助力A型血变身“万能血”, objectType=article, longId=168752, objectId=95a4168e52ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95a4168e52ea, replyNumber=0, likeNumber=74, createdTime=2019-07-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95a4168e52ea, moduleTitle=Nat Micro：肠道细菌助力A型血变身“万能血”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95a4168e52ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678146, encodeId=1fa916e8146f7, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=能将A型血转为O型血的酶被发现！有望缓解供血短缺, objectType=article, longId=168791, objectId=f06d168e9191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f06d168e9191, replyNumber=0, likeNumber=65, createdTime=2019-11-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f06d168e9191, moduleTitle=能将A型血转为O型血的酶被发现！有望缓解供血短缺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f06d168e9191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678139, encodeId=dbe916e8139a2, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=拜耳旗下Jivi获得欧盟批准用于治疗及预防A型血友病, objectType=article, longId=154587, objectId=495f15458ec8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=495f15458ec8, replyNumber=0, likeNumber=60, createdTime=2019-09-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=495f15458ec8, moduleTitle=拜耳旗下Jivi获得欧盟批准用于治疗及预防A型血友病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=495f15458ec8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678147, encodeId=12ba16e81475c, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=2019年国际血栓形成和止血学会（ISTH）大会，辉瑞/Sangamo的A型血友病基因疗法显示出持续增加的凝血因子VIII水平, objectType=article, longId=175017, objectId=1c911e501782, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c911e501782, replyNumber=0, likeNumber=62, createdTime=2020-01-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c911e501782, moduleTitle=2019年国际血栓形成和止血学会（ISTH）大会，辉瑞/Sangamo的A型血友病基因疗法显示出持续增加的凝血因子VIII水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c911e501782)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678138, encodeId=92fe16e813873, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=FDA批准罗氏A型血友病重磅药Hemlibra获批, objectType=article, longId=150489, objectId=aa11150489d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa11150489d3, replyNumber=0, likeNumber=54, createdTime=2019-02-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa11150489d3, moduleTitle=FDA批准罗氏A型血友病重磅药Hemlibra获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa11150489d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678141, encodeId=167516e8141fa, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Stem Cell Research & Therapy：联合移植技术让基因治疗成为A型血友病更具前景的治疗方法, objectType=article, longId=163066, objectId=e23b163066a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e23b163066a2, replyNumber=0, likeNumber=103, createdTime=2019-12-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e23b163066a2, moduleTitle=Stem Cell Research & Therapy：联合移植技术让基因治疗成为A型血友病更具前景的治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e23b163066a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678134, encodeId=5b2516e813466, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Blood：TAFI激活缺陷是A型血友病关节出血的主要原因, objectType=article, longId=144821, objectId=f8d2144821f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8d2144821f3, replyNumber=0, likeNumber=58, createdTime=2018-11-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8d2144821f3, moduleTitle=Blood：TAFI激活缺陷是A型血友病关节出血的主要原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8d2144821f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678142, encodeId=0a2916e8142d6, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Lancet Haematol：Emicizumab用于A型血友病出血预防, objectType=article, longId=164518, objectId=97741645181b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97741645181b, replyNumber=0, likeNumber=71, createdTime=2020-04-02, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97741645181b, moduleTitle=Lancet Haematol：Emicizumab用于A型血友病出血预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97741645181b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678136, encodeId=16c116e813645, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=拜尔A型血友病药物Jivi获得FDA批准, objectType=article, longId=147909, objectId=ab0414e909e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab0414e909e9, replyNumber=0, likeNumber=85, createdTime=2018-10-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab0414e909e9, moduleTitle=拜尔A型血友病药物Jivi获得FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab0414e909e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678137, encodeId=b74d16e81375c, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=拜耳旗下A型血友病药物Jivi在日本获批, objectType=article, longId=149519, objectId=5b97149519a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b97149519a1, replyNumber=0, likeNumber=55, createdTime=2019-07-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b97149519a1, moduleTitle=拜耳旗下A型血友病药物Jivi在日本获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b97149519a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678135, encodeId=ae3316e813579, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=NEJM：Emicizumab用于预防A型血友病患者出血, objectType=article, longId=147773, objectId=aadd14e7739a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aadd14e7739a, replyNumber=0, likeNumber=90, createdTime=2019-06-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aadd14e7739a, moduleTitle=NEJM：Emicizumab用于预防A型血友病患者出血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aadd14e7739a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678132, encodeId=47c416e813271, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=世界嗓音日：A型血更易患嗓音疾病, objectType=article, longId=135705, objectId=8df1135e0575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8df1135e0575, replyNumber=0, likeNumber=70, createdTime=2019-01-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8df1135e0575, moduleTitle=世界嗓音日：A型血更易患嗓音疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8df1135e0575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678133, encodeId=62a116e81331e, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Octapharma在2018年世界血友病联盟会议上展示Nuwiq对A型血友病患者的益处, objectType=article, longId=139446, objectId=5f7e13944643, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f7e13944643, replyNumber=0, likeNumber=68, createdTime=2019-04-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f7e13944643, moduleTitle=Octapharma在2018年世界血友病联盟会议上展示Nuwiq对A型血友病患者的益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f7e13944643)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678130, encodeId=9df916e813015, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=NEJM：emicizumab可降低体内出现抑制剂的A型血友病患者87%出血事件的发生率！, objectType=article, longId=105412, objectId=c52a105412b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c52a105412b0, replyNumber=0, likeNumber=69, createdTime=2017-11-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c52a105412b0, moduleTitle=NEJM：emicizumab可降低体内出现抑制剂的A型血友病患者87%出血事件的发生率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c52a105412b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678131, encodeId=c52c16e8131e8, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=FDA批准Hemlibra用于减少或防止某些A型血友病的出血频率, objectType=article, longId=120686, objectId=9f89120686a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f89120686a6, replyNumber=0, likeNumber=75, createdTime=2018-10-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f89120686a6, moduleTitle=FDA批准Hemlibra用于减少或防止某些A型血友病的出血频率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f89120686a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678128, encodeId=95a816e8128dc, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=罗氏A型血液病预防性治疗药物emicizumabIII期临床获得成功, objectType=article, longId=85803, objectId=b71585803c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b71585803c3, replyNumber=0, likeNumber=67, createdTime=2017-07-19, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b71585803c3, moduleTitle=罗氏A型血液病预防性治疗药物emicizumabIII期临床获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b71585803c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678129, encodeId=9e6816e8129f3, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=INT J LAB HEMATOL：中国南方A型血友病的遗传诊断：五个新突变和一个植入前遗传分析, objectType=article, longId=95907, objectId=3cee9590e57, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cee9590e57, replyNumber=0, likeNumber=127, createdTime=2017-08-02, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cee9590e57, moduleTitle=INT J LAB HEMATOL：中国南方A型血友病的遗传诊断：五个新突变和一个植入前遗传分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cee9590e57)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678127, encodeId=e6a816e81274a, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=FDA批准治疗A型血友病单链凝血因子的药物AFSTYLA, objectType=article, longId=69537, objectId=4c3d6953ec0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c3d6953ec0, replyNumber=0, likeNumber=112, createdTime=2016-06-27, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c3d6953ec0, moduleTitle=FDA批准治疗A型血友病单链凝血因子的药物AFSTYLA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c3d6953ec0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

A型血

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Lancet haemat：A型血友病患者采用emicizumab预防出血的效果和安全性

2020-02-21

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

诺和诺德的长效化凝血因子VIII（ESPEROCT）获FDA批准治疗A型血友病

2019-05-11

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Nat Micro：肠道细菌助力A型血变身“万能血”

2019-07-30

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

能将A型血转为O型血的酶被发现！有望缓解供血短缺

2019-11-25

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

拜耳旗下Jivi获得欧盟批准用于治疗及预防A型血友病

2019-09-17

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

2019年国际血栓形成和止血学会（ISTH）大会，辉瑞/Sangamo的A型血友病基因疗法显示出持续增加的凝血因子VIII水平

2020-01-07

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

FDA批准罗氏A型血友病重磅药Hemlibra获批

2019-02-25

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Stem Cell Research & Therapy：联合移植技术让基因治疗成为A型血友病更具前景的治疗方法

2019-12-29

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Blood：TAFI激活缺陷是A型血友病关节出血的主要原因

2018-11-06

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Lancet Haematol：Emicizumab用于A型血友病出血预防

2020-04-02

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

拜尔A型血友病药物Jivi获得FDA批准

2018-10-14

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

拜耳旗下A型血友病药物Jivi在日本获批

2019-07-27

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

NEJM：Emicizumab用于预防A型血友病患者出血

2019-06-20

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

世界嗓音日：A型血更易患嗓音疾病

2019-01-03

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Octapharma在2018年世界血友病联盟会议上展示Nuwiq对A型血友病患者的益处

2019-04-08

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

NEJM：emicizumab可降低体内出现抑制剂的A型血友病患者87%出血事件的发生率！

2017-11-30

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

FDA批准Hemlibra用于减少或防止某些A型血友病的出血频率

2018-10-05

仁心济世 (审核中...)

前往app查看评论内容

#A型血#

罗氏A型血液病预防性治疗药物emicizumabIII期临床获得成功

2017-07-19

仁心济世 (审核中...)

前往app查看评论内容

#A型血#

INT J LAB HEMATOL：中国南方A型血友病的遗传诊断：五个新突变和一个植入前遗传分析

2017-08-02

仁心济世 (审核中...)

前往app查看评论内容

#A型血#

FDA批准治疗A型血友病单链凝血因子的药物AFSTYLA

2016-06-27

科室
- - 订阅+
  - 更多科室
工具
服务